Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maksimov M.L.
Observed name:
M.L. Maksimov
Institutions:
Pirogov Russian National Research Medical University,
Russian Medical Academy of Continuous Professional Education,
Ministry of Health of the Russian Federation
Observed institutions:
Sechenov University,
Pirogov Russian National Research Medical University,
Russian Medical Academy of Continuous Professional Education,
Ministry of Health of the Russian Federation
ORCID:
0000-0002-8979-8084
Observed ORCID:
0000-0002-8979-8084
OpenAlex ID:
A5107876293
Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
2017
·
M.L. Maksimov
, O.V. Dralova
·
Systemic Hypertension
·
4
Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs
2016
·
O.D. Ostroumova
, A.A. Zykova
, et al.
·
Systemic Hypertension
·
2
International Safety Profile for the Use of Omalizumab in Clinical Practice
2024
·
Schneider K.O.
, Maksimov M.L.
, et al.
·
Bulletin Biomedicine and sociology
·
1
Comprehensive Analysis of the Causes of Adverse Reactions to Omalizumab
2024
·
Maksimov M.L.
, Schneider K.O.
, et al.
·
Bulletin Biomedicine and sociology
Safety of Omalizumab in Different Patient Populations
2024
·
Kondrakhin A.P.
, Maksimov M.L.
, et al.
·
Bulletin Biomedicine and sociology
Use of Humanized Off-label Monoclonal Antibodies in Pediatric Practice
2023
·
Schneider K.O.
, Maksimov M.L.
, et al.
·
Bulletin Biomedicine and sociology
Show more works
View as search
Works count:
6
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type